Hyong Kim Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 months, 1 week ago
Hyong Kim has an estimated net worth of at least $10.1 million*, as of June 11, 2025. They own 472,167 shares of ALHC stock. They have sold 205,404 shares of ALHC stock since 2021, for an estimated $2.3 million.
Hyong Kim $ALHC SEC Form 4 Insider Trading
Hyong Kim has filed a total of 12 insider trades in $ALHC since 2021. Their most recent trade was a sale of 18,600 shares, made on Aug 13, 2025. Their largest trade was a sale of 62,574 shares, made on Dec 05, 2024. We estimate that they now own 472,167 shares of $ALHC, worth an estimated $7.8 million.
Insider Trading at $ALHC
There have been a total of 285 insider trades reported at $ALHC since 2021, with 203,000 shares purchased and 86.7 million shares sold. The most active insider traders in $ALHC stock have been Robert Thomas Freeman, John E Kao, and Dawn Christine Maroney. The most recent trade was a sale of 18,600 shares reported by Hyong Kim (Chief Medical Officer), made on Aug 13, 2025.
History of Insider Stock Trades by Hyong Kim
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ALHC
|
Sale | 18,600 | Aug 13, 2025 | Aug. 15, 2025, 4:31 p.m. |
|
ALHC
|
Sale | 18,600 | Aug 11, 2025 | Aug. 13, 2025, 4:24 p.m. |
|
ALHC
|
Sale | 26,734 | Mar 20, 2025 | March 21, 2025, 7:12 p.m. |
|
ALHC
|
Sale | 2,971 | Mar 19, 2025 | March 19, 2025, 9:50 p.m. |
|
ALHC
|
Sale | 5,295 | Mar 19, 2025 | March 19, 2025, 9:50 p.m. |
|
ALHC
|
Sale | 21,006 | Mar 07, 2025 | March 7, 2025, 7:37 p.m. |
|
ALHC
|
Sale | 568 | Mar 07, 2025 | March 7, 2025, 7:37 p.m. |
|
ALHC
|
Sale | 13,394 | Mar 05, 2025 | March 6, 2025, 8:31 p.m. |
|
ALHC
|
Sale | 7,626 | Mar 06, 2025 | March 6, 2025, 8:31 p.m. |
|
ALHC
|
Sale | 62,574 | Dec 05, 2024 | Dec. 6, 2024, 5:30 p.m. |
|
ALHC
|
Sale | 22,460 | Oct 08, 2024 | Oct. 10, 2024, 6:58 p.m. |
|
ALHC
|
Sale | 5,576 | Mar 19, 2024 | March 21, 2024, 5 p.m. |
$ALHC Executives and Stock Owners with Insider Trades
-
Robert Thomas Freeman, Chief Financial Officer
-
John E Kao, Chief Executive Officer
-
Dawn Christine Maroney, President, Markets
-
Christopher J Joyce, Chief Legal and Admin. Officer
-
Dinesh M. Kumar, Chief Med & Operating Officer
-
Hakan Kardes, Chief Experience Officer
-
Dawn Christine Maroney, President
-
Hyong Kim, Chief Medical Officer
-
Robert L. Scavo, Chief Information Officer
-
Andreas P. Wagner, Chief Human Resources Officer
-
Dinesh M. Kumar, Chief Medical Officer
-
Joseph S Konowiecki, Chairman of the Board
-
Richard A. Cross, SVP, General Counsel
-
Sebastian Burzacchi, COO - Mgmt Services Org
-
Donald Steven Furman, Chief Clinical Officer
-
Rajesh Shrestha, Pres., New Markets & CBO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.